04.02.2018
- Lending fuel to the ongoing controversy in the Philippines over the possible side effects of Sanofi Pasteur 's Dengue vaccine Dengvaxia, an initial report by the Philippine General...
30.01.2018
- Sanofi is to acquire Belgium biopharma Ablynx in a deal valued at around €3.9 billion. The announcement comes just days after the French drugmaker announced its intention to buy US...
24.01.2018
- Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...
23.01.2018
- French vaccines producer Sanofi Pasteur, under pressure from the government of the Philippines, has agreed to refund the country $28 million for unused doses of its Dengvaxia...
08.01.2018
- The year just ended was marked by a flood of M&A activity also in the distribution sector. Leading the way, German giant Brenntag said it planned to acquire all shares of specialty...
08.01.2018
- On the pharmaceutical side, super-dimensioned M&A activity was somewhat more modest. Many of the deals were between players in the biochemicals segment or conventional drugmakers...
08.01.2018
- The chemical production sector saw more activity than pharmaceuticals in 2017. Beyond the mega-mergers, one of the most significant deals of 2017 was BASF’s announcement in early...
08.01.2018
- Mergers and acquisitions, new petrochemical projects, the dismantling of US environmental regulations, and a tussle over the hazards of pesticides in Europe, along with a...
03.01.2018
- UK drugmaker GlaxoSmithKline (GSK) has expanded its stake in its Saudi subsidiary Glaxo Saudi Arabia Limited (GSAL) by 26% to 75%. With an investment of more than $243 million, the...
04.12.2017
- Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...